Eligo Bioscience
PrivateLast Round
Grant
May 13, 2025
Total Funding Raised
$65.34M
Company Overview
Eligo Bioscience operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Grant round in May 2025.
Eligo Bioscience is a biotechnology company that develops in vivo gene editing technologies to modulate the microbiome for the treatment of bacteria-associated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eligo Bioscience Comparables
Compare Eligo Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SNIPR Biome | 88% | |
| Locus Biosciences | 85% | |
| Nemesis Bioscience | 83% |
For institutional investors. Book with your work email.
Eligo Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2025 | ||||
| Series B | Dec 5, 2023 | ||||
| Grant | May 1, 2019 | ||||
| Series A | Sep 26, 2017 | ||||
| Seed | Jul 8, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eligo Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series B, Series A |
| European Commission | Grant |
| Government of France | Grant |
| Sanofi Ventures | Series B |
| Bpifrance | Series B, Grant |
| Seventure Partners | Series A, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
Recognized as one of the World Economic Forum’s 30 Most Innovative Companies.
- May 13, 2025
Partnered with Biose Industries for microbial fermentation.
For institutional investors. Book with your work email.
Eligo Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eligo Bioscience's valuation, stock price, and market status.
Is Eligo Bioscience a public or private company?
Eligo Bioscience is a private company.
What is the current stock price of Eligo Bioscience?
Eligo Bioscience is a private company, so its shares have no public market price. Caplight tracks Eligo Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eligo Bioscience worth (valuation)?
Valuation information for Eligo Bioscience is not publicly available.
Can I buy Eligo Bioscience stock?
Eligo Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eligo Bioscience's last funding round?
Eligo Bioscience's most recent funding round was Grant on May 13, 2025.
Who are the main investors in Eligo Bioscience?
Key investors in Eligo Bioscience include Khosla Ventures, Sanofi Ventures, Seventure Partners.
Will Eligo Bioscience IPO soon?
No public IPO plans have been announced for Eligo Bioscience.
How can I track Eligo Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Eligo Bioscience's shares on secondary markets.